MUC16 and ovarian cancer: Furthermore, Sinyoung Jeong et al.39proposed that MUC16 may bind to the SIGLEC9 receptor on Natural Killer (NK) cells, leading to the downregulation of NK cell cytotoxicity and enabling ovarian cancer cells to evade immune surveillance.